<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04268381</url>
  </required_header>
  <id_info>
    <org_study_id>20-2T/39</org_study_id>
    <nct_id>NCT04268381</nct_id>
  </id_info>
  <brief_title>Oral and Systemic aMMP-8 in Periodontal Disease</brief_title>
  <official_title>Local And Systemic Levels of aMMP-8 in Gingivitis and Stage 3 Periodontitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aydin Adnan Menderes University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Giresun University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aydin Adnan Menderes University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Periodontal disease is an inflammatory process that can result in tooth loss and also is
      considered a modifying factor for systemic health. Matrix metalloproteinase (MMP)-8 is the
      major collagenase of periodontal tissue breakdown. The aim of the present study is to analyze
      active (aMMP-8) levels in gingival crevicular fluid (GCF), saliva and serum in the context of
      new criteria of gingivitis and stage 3 grade C periodontitis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 20, 2020</start_date>
  <completion_date type="Actual">March 20, 2020</completion_date>
  <primary_completion_date type="Actual">March 20, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Oral (GCF and saliva) and serum levels of aMMP-8 in periodontitis and gingivitis</measure>
    <time_frame>through study completion, an average of 4 months</time_frame>
    <description>aMMP-8 levels</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">83</enrollment>
  <condition>Periodontal Diseases</condition>
  <condition>Periodontal Inflammation</condition>
  <arm_group>
    <arm_group_label>Healthy (n=23)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Gingivitis (n=20)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Periodontitis (n=40)</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biochemical analysis</intervention_name>
    <description>aMMP-8 is measured by immunofluorometric assay (IFMA).</description>
    <arm_group_label>Gingivitis (n=20)</arm_group_label>
    <arm_group_label>Healthy (n=23)</arm_group_label>
    <arm_group_label>Periodontitis (n=40)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy controls (n=23) includes volunteers with clinically healthy periodontium who had
        BOP &lt; 10% and PD ≤ 3 mm, no sites with &gt; 1 mm attachment loss, no radiographic sign of
        alveolar bone destruction and no history of periodontitis. Gingivitis patients (n=20) shows
        PD ≤ 3 mm with BOP &gt; 50% in the entire mouth as well as no clinical attachment loss or
        alveolar bone loss. Periodontitis patients (Generalized Stage 3) have interdental CAL ≥ 5
        mm at least 2 non-adjacent teeth, PD ≥ 6 mm and radiographic bone loss affecting 30% of the
        teeth or more.They show also no more than 4 teeth loss due to periodontitis.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  systemically healthy and non-smoker individuals aged 25 to 50 years

          -  having ≥20 teeth present (except third molars)

          -  individuals with periodontally healthy, gingivitis and stage 3 periodontitis diagnoses

        Exclusion Criteria:

          -  having any systemic disease

          -  smoking

          -  pregnancy or lactation

          -  using antibiotic or any anti-inflammatory drug or any periodontal treatment within the
             past 6 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zeynep Pinar Keles Yucel</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Periodontology, School of Dentistry, Giresun University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aydin Adnan Menderes University</name>
      <address>
        <city>Aydın</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>February 10, 2020</study_first_submitted>
  <study_first_submitted_qc>February 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2020</study_first_posted>
  <last_update_submitted>July 10, 2020</last_update_submitted>
  <last_update_submitted_qc>July 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Giresun University</investigator_affiliation>
    <investigator_full_name>Zeynep Pinar KELES YUCEL</investigator_full_name>
    <investigator_title>Assistant Prof.</investigator_title>
  </responsible_party>
  <keyword>periodontitis</keyword>
  <keyword>gingivitis</keyword>
  <keyword>matrix metalloproteinases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontal Diseases</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

